Microbiome therapies: why we are not there yet
نویسندگان
چکیده
Microbiome therapies have the potential to revolutionise our approach medicine, but until now, a lack of standardisation and regulation has hampered clinical development. Here, Chrysi Sergaki Jack Hassall from National Institute for Biological Standards Control discuss how they are developing reference reagents standardise analysis microbiome samples, research is now moving towards development more targeted microbiome-based therapeutics.
منابع مشابه
"Are we there yet?".
Changes in laws are reflected – even foreshadowed on occasion – by the field’s scholarship. In the 1980s, there were few who recognized that adults with disabilities were an important resource in the education of students with disabilities or that issues of race and culture had consequence for identifying and delivering services to these children. It is striking that this special issue of the L...
متن کاملAre We There Yet?
Statistical approaches to Artificial Intelligence are behind most success stories of the field in the past decade. The idea of generating non-trivial behaviour by analysing vast amounts of data has enabled recommendation systems, search engines, spam filters, optical character recognition, machine translation and speech recognition, among other things. As we celebrate the spectacular achievemen...
متن کاملAre We There Yet?
Children in the back seat on a long trip are not the only ones asking the question “Are we there yet?” At Murray State University (MSU) and other universities starting new programs, the question becomes one of validation of the program. In the late 90s, MSU, a midsize university, was entrusted with the responsibility of developing a program of distinction with financial support from special sta...
متن کاملAre We There Yet?
've always been an avid traveler and often look forward to planning summer trips to faraway destinations. However , whether by train, plane, or automobile , long-distance travel for the majority of us usually comes with some degree of discomfort—long periods of time sitting in a seat with a limited selection of things to do. Fun traveling companions and a good book can help, but faced with a lo...
متن کاملMyocardial Inflammation—Are We There Yet?
Several exogenous or endogenous factors can lead to inflammatory heart disease. Beside infectious myocarditis, other systemic inflammatory disorders such as sarcoidosis, systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Churg-Strauss syndrome, and rheumatoid arthritis can affect the myocardium. Myocardial inflammation may have a major impact on the outcome of these patients, resulti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Prescriber
سال: 2022
ISSN: ['0959-6682', '1931-2253']
DOI: https://doi.org/10.1002/psb.1972